Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

WISTUBA, IGNACIO IVAN

One or more keywords matched the following items that are connected to WISTUBA, IGNACIO IVAN

Item Type	Name
Academic Article	A phase II study of gefitinib for aggressive cutaneous squamous cell carcinoma of the head and neck.
Concept	Quinazolines
Academic Article	Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cells.
Academic Article	High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor.
Academic Article	HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy.
Academic Article	Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion.
Academic Article	An integrin ?3-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition.
Academic Article	Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation.
Academic Article	Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis.
Academic Article	KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer.
Academic Article	Clinical outcomes and biomarker profiles of elderly pretreated NSCLC patients from the BATTLE trial.
Academic Article	Clinical and biomarker outcomes of the phase II vandetanib study from the BATTLE trial.
Academic Article	The relative expression of Mig6 and EGFR is associated with resistance to EGFR kinase inhibitors.
Academic Article	Vandetanib and indwelling pleural catheter for non-small-cell lung cancer with recurrent malignant pleural effusion.
Academic Article	Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transition.
Academic Article	Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung Cancer.
Academic Article	KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI Vandetanib.
Academic Article	Phase I Trial of Cediranib in Combination with Cisplatin and Pemetrexed in Chemonaive Patients with Unresectable Malignant Pleural Mesothelioma (SWOG S0905).
Academic Article	Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with ?-blockers.
Academic Article	Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Na?ve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905).
Academic Article	Biomarker analyses from a placebo-controlled phase II study evaluating erlotinib?onartuzumab in advanced non-small cell lung cancer: MET expression levels are predictive of patient benefit.

Search Criteria

Quinazolines